miR-183/TMSB4Y, a new potential signaling axis, involving in the progression of laryngeal cancer via modulating cell adhesion

References

• Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386–396.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Cancer Stat Facts: Laryngeal Cancer 2020. Available from: https://seer.cancer.gov/statfacts/html/laryn.html
   Google Scholar
• Saito K, Inagaki K, Kamimoto T, et al. MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer. PLoS One. 2013;8(8):e71480.
   PubMed Web of Science ®Google Scholar
• Du L, Li H, Zhu C, et al. Incidence and mortality of laryngeal cancer in China, 2011. Chin J Cancer Res. 2015;27(1):52–58.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.
   Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338.
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya S, Sonenberg NN. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9(2):102–114.
   PubMed Web of Science ®Google Scholar
• Ziegler C, Kretz M. The More the Merrier-Complexity in Long Non-Coding RNA Loci. Front Endocrinol (Lausanne)). 2017;8:90.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Flynt AS, Lai EC. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet. 2008;9(11):831–842.
   PubMed Web of Science ®Google Scholar
• Wang H, Ma Z, Liu X, et al. MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN. Biomed Pharmacother. 2019;111:1103–1111.
   PubMed Web of Science ®Google Scholar
• Chen D, Li SG, Chen JY, et al. MiR-183 maintains canonical Wnt signaling activity and regulates growth and apoptosis in bladder cancer via targeting AXIN2. Eur Rev Med Pharmacol Sci. 2018;22(15):4828–4836.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang W, Zhang X, et al. Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases chemosensitivity to 5-fluorouracil and gemcitabine. Exp Ther Med. 2019;17:1697–1705.
   PubMed Web of Science ®Google Scholar
• Maia D, de Carvalho AC, Horst MA, et al. Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma. J Transl Med. 2015;13:262
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008;19(1):92–105.
   PubMed Web of Science ®Google Scholar
• Wong HY, Wang GM, Croessmann S, et al. TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer. Oncotarget. 2015;6(42):44927–44940.
   PubMedGoogle Scholar
• Dasari VK, Goharderakhshan RZ, Perinchery G, et al. Expression analysis of Y chromosome genes in human prostate cancer. J Urol. 2001;165(4):1335–1341.
   PubMed Web of Science ®Google Scholar
• Obid R, Redlich M, Tomeh C. The treatment of laryngeal cancer. Oral Maxillofac Surg Clin North Am. 2019;31(1):1–11.
   PubMed Web of Science ®Google Scholar
• Chen H, Jin L, Zhou L, et al. Overexpressed miR-128a enhances chemoradiotherapy to laryngeal cancer cells and its correlation with BMI1. Future Oncol. 2018;14(7):611–620.
   PubMed Web of Science ®Google Scholar
• Lampri ES, Chondrogiannis G, Ioachim E, et al. Biomarkers of head and neck cancer, tools or a gordian knot. Int J Clin Exp Med. 2015;8(7):10340–10357.
   PubMed Web of Science ®Google Scholar
• Li X, Cao Y, Gong X, et al. Long noncoding RNAs in head and neck cancer. Oncotarget. 2017;8(6):10726–10740.
   PubMedGoogle Scholar
• Yu X, Li Z. The role of microRNAs expression in laryngeal cancer. Oncotarget. 2015;6(27):23297–23305.
   PubMedGoogle Scholar
• Feng WT, Yao R, Xu LJ, et al. Effect of miR-363 on the proliferation, invasion and apoptosis of laryngeal cancer by targeting Mcl-1. Eur Rev Med Pharmacol Sci. 2018;22(14):4564–4572.
   PubMed Web of Science ®Google Scholar
• Karatas OF. Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1. Head Neck. 2018;40(11):2455–2461.
   PubMed Web of Science ®Google Scholar
• Miao S, Mao X, Zhao S, et al. miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression. Oncotarget. 2017;8(37):62143–62153.
   PubMedGoogle Scholar
• Zhang Q, Ren W, Huang B, et al. MicroRNA-183/182/96 cooperatively regulates the proliferation of colon cancer cells. Mol Med Rep. 2015;12(1):668–674.
   PubMed Web of Science ®Google Scholar
• Xiong H, Chen R, Liu S, et al. MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1. J Cell Biochem. 2018;119(10):8123–8137.
   PubMed Web of Science ®Google Scholar
• Song C, Zhang L, Wang J, et al. High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer. Sci Rep. 2016;6:24502
   PubMed Web of Science ®Google Scholar
• Suzuki R, Amatya VJ, Kushitani K, et al. miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma. Front Oncol. 2018;8:446
   PubMed Web of Science ®Google Scholar
• Yang X, Wang L, Wang Q, et al. MiR-183 inhibits osteosarcoma cell growth and invasion by regulating LRP6-Wnt/β-catenin signaling pathway. Biochem Biophys Res Commun. 2018;496(4):1197–1203.
   PubMed Web of Science ®Google Scholar
• Meng F, Zhang L. miR-183-5p functions as a tumor suppressor in lung cancer through PIK3CA inhibition. Exp Cell Res. 2019;374(2):315–322.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009;136(4):586–591.
   PubMed Web of Science ®Google Scholar
• Bachtrog D. Y-chromosome evolution: emerging insights into processes of Y-chromosome degeneration. Nat Rev Genet. 2013;14(2):113–124.
   PubMed Web of Science ®Google Scholar
• Mitchell EL. A cytogenetic study of male breast cancer. Cancer Genet Cytogenet. 1990;47(1):107–112.
   PubMedGoogle Scholar
• Teixeira MR, Pandis N, Dietrich CU, et al. Chromosome banding analysis of gynecomastias and breast carcinomas in men. Genes Chromosom Cancer. 1998;23(1):16–20.
   PubMed Web of Science ®Google Scholar
• Xu M, Feng X, Feng F, et al. Magnetic nanoparticles for the measurement of cell mechanics using force-induced remnant magnetization spectroscopy. Nanoscale. 2020;12(27):14573–14580.
   Google Scholar
• Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991;113(1):173–185.
   PubMed Web of Science ®Google Scholar
• Vitoria WO, Thomé LS, Kanashiro-Galo L, et al. Upregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in renal tissue in severe dengue in humans: Effects on endothelial activation/dysfunction. Rev Soc Bras Med Trop. 2019;52:e20180353.
   PubMed Web of Science ®Google Scholar